You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | n/a |
Div Cover | n/a | n/a |
Op Mrgn | 0.0% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -3.6 | n/a |
PEG | 0.0 | n/a |
Price / Revenue | 0.0 | n/a |
Price / Book value | 2.9 |
Latest | Forecast | |
---|---|---|
Revenue | n/a | n/a |
PBT | 0.0% | n/a |
EPS | 0.0% | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2020-12-31 | n/a | -0.51 | -1.89p | 0.0 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | n/a | -2.53 | -6.02p | -4.9 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | n/a | -2.97 | -3.78p | -4.5 | 0.0 | n/a | n/a | 0.0% |
2023-12-31 | n/a | -3.00 | -3.50p | -3.0 | 0.0 | n/a | n/a | 0.0% |
BiVictriX gets patent for its lead asset in Japan Sharecast News | 15 Nov |
---|---|
BiVictriX posts promising preclinical data on leukaemia candidate Sharecast News | 12 Oct |
BiVictriX appoints Adrian Howd as its new finance chief Sharecast News | 03 Oct |
Publication of 2023 Annual Report & Notice of AGM | 26-Jun-24 07:01 |
---|---|
Compelling Safety Profile of BVX001 | 13-Jun-24 07:01 |
Innovate UK Grant Award to Accelerate ADC Pipeline | 06-Jun-24 07:01 |
BiVictriX – Full Year Results 2023 | 31-May-24 08:44 |
Orphan Drug Designation & FDA INTERACT Meeting | 17-Apr-24 07:01 |